Cargando…
Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carb...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676825/ https://www.ncbi.nlm.nih.gov/pubmed/18203436 |
_version_ | 1782166774927589376 |
---|---|
author | Wang, Jinzhong Plourde, Nicole M Iverson, Nicole Moghe, Prabhas V Uhrich, Kathryn E |
author_facet | Wang, Jinzhong Plourde, Nicole M Iverson, Nicole Moghe, Prabhas V Uhrich, Kathryn E |
author_sort | Wang, Jinzhong |
collection | PubMed |
description | A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average size of 20–35 nm, and display critical micelle concentration values as low as 10(−7) M. Their charge densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups located in the hydrophobic block destabilize micelle formation more than carboxylate groups in the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of hoxLDL by macrophages, inhibition efficiency was influenced by the quantity and location of the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and charge density is critical for inhibiting hoxLDL uptake by macrophages. |
format | Text |
id | pubmed-2676825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26768252009-05-12 Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture Wang, Jinzhong Plourde, Nicole M Iverson, Nicole Moghe, Prabhas V Uhrich, Kathryn E Int J Nanomedicine Original Research A series of novel amphiphilic macromolecules composed of alkyl chains as the hydrophobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average size of 20–35 nm, and display critical micelle concentration values as low as 10(−7) M. Their charge densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups located in the hydrophobic block destabilize micelle formation more than carboxylate groups in the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of hoxLDL by macrophages, inhibition efficiency was influenced by the quantity and location of the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and charge density is critical for inhibiting hoxLDL uptake by macrophages. Dove Medical Press 2007-12 2007-12 /pmc/articles/PMC2676825/ /pubmed/18203436 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Original Research Wang, Jinzhong Plourde, Nicole M Iverson, Nicole Moghe, Prabhas V Uhrich, Kathryn E Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title | Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title_full | Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title_fullStr | Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title_full_unstemmed | Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title_short | Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
title_sort | nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676825/ https://www.ncbi.nlm.nih.gov/pubmed/18203436 |
work_keys_str_mv | AT wangjinzhong nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture AT plourdenicolem nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture AT iversonnicole nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture AT mogheprabhasv nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture AT uhrichkathryne nanoscaleamphiphilicmacromoleculesaslipoproteininhibitorstheroleofchargeandarchitecture |